Adam M. Veness, SVP, General Counsel and Secretary at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 20,000 shares at $110.61 ($2.2M) on 2026-08-07, disclosed to the SEC on 2026-08-11.
Scheduled sale ($2.2M) by SVP, General Counsel and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.61 | 3,217 | $356K | 16.1% |
| 2 | $111.18 | 616 | $68K | 3.1% |
| 3 | $110.38 | 16,167 | $1.8M | 80.8% |
| Total | $110.44 avg | 20,000 | $2.2M | 100% |
| Filing → |
| XLRN | SELL | 2021-09-09 | $184K | — | Filing → |
| XLRN | SELL | 2021-01-06 | $252K | — | Filing → |
| XLRN | SELL | 2020-09-09 | $358K | — | Filing → |